Abstract
Objective. The objective of this study was to compare the cost-effectiveness of various treatment modalities for hemiplegic shoulder pain. Design. A stage II economic evaluation. Main outcome measures. Incremental cost effectiveness ratio of P-NMES, compared to slings and anti-inflammatory injections. Results. The incremental cost effectiveness ratio (ICER) of p-NMES, compared to anti-inflammatory injections is €6,061 (±3,285). The incremental cost of the first quality-adjusted life year after implantation of the P-NMES device compared to anti-inflammatory injections is €33,007 (±5,434). This decreases to ≈ €7,000 after 5 years, and to ≈ €5,000 after 10 survival years. Conclusion. In this early evaluation, P-NMES seems to be cost-effective according to known guidelines. Treatment with P-NMES is recommended for patients with chronic HSP.
| Original language | English |
|---|---|
| Pages (from-to) | 645-651 |
| Number of pages | 7 |
| Journal | Disability and Rehabilitation |
| Volume | 28 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - May 2006 |
| Externally published | Yes |
Bibliographical note
Funding Information:This research was sponsored by NeuroControl Corporation (NCC), Cleveland, Ohio. NCC intends to commercialize the device evaluated in this paper. NCC had no influence at all in relation to this work. NCC provided financial support for the execution of this study and allowed a discount on the purchase of P-NMES devices for the clinical trial that was performed in our rehabilitation center.
